Literature DB >> 33924927

Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines.

Euan J Rodger1,2, Suzan N Almomani1,2, Jackie L Ludgate1, Peter A Stockwell1, Bruce C Baguley2, Michael R Eccles1,2, Aniruddha Chatterjee1,2.   

Abstract

DNA methylation is a heritable epigenetic mark that is fundamental to mammalian development. Aberrant DNA methylation is an epigenetic hallmark of cancer cells. Cell lines are a critical in vitro model and very widely used to unravel mechanisms of cancer cell biology. However, limited data are available to assess whether DNA methylation patterns in tissues are retained when cell lines are established. Here, we provide the first genome-scale sequencing-based methylation map of metastatic melanoma tumour tissues and their derivative cell lines. We show that DNA methylation profiles are globally conserved in vitro compared to the tumour tissue of origin. However, we identify sites that are consistently hypermethylated in cell lines compared to their tumour tissue of origin. The genes associated with these common differentially methylated regions are involved in cell metabolism, cell cycle and apoptosis and are also strongly enriched for the H3K27me3 histone mark and PRC2 complex-related genes. Our data indicate that although global methylation patterns are similar between tissues and cell lines, there are site-specific epigenomic differences that could potentially impact gene expression. Our work provides a valuable resource for identifying false positives due to cell culture and for better interpretation of cancer epigenetics studies in the future.

Entities:  

Keywords:  cancer; cell culture; epigenetics; in vitro; methylation

Year:  2021        PMID: 33924927     DOI: 10.3390/cancers13092123

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  71 in total

1.  5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.

Authors:  R J Wozniak; W T Klimecki; S S Lau; Y Feinstein; B W Futscher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

2.  Systematic DNA methylation analysis of multiple cell lines reveals common and specific patterns within and across tissues of origin.

Authors:  Xiaofei Yang; Xiaojian Shao; Lin Gao; Shihua Zhang
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

Review 3.  Tools and Strategies for Analysis of Genome-Wide and Gene-Specific DNA Methylation Patterns.

Authors:  Aniruddha Chatterjee; Euan J Rodger; Ian M Morison; Michael R Eccles; Peter A Stockwell
Journal:  Methods Mol Biol       Date:  2017

Review 4.  H3K27 methylation: a promiscuous repressive chromatin mark.

Authors:  Elizabeth T Wiles; Eric U Selker
Journal:  Curr Opin Genet Dev       Date:  2016-12-08       Impact factor: 5.578

5.  Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line.

Authors:  Lama Hamadneh; May Al-Majawleh; Yazun Jarrar; Sawsan Shraim; Mariam Hasan; Basha'er Abu-Irmaileh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-04-09       Impact factor: 2.416

6.  Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome.

Authors:  Cinzia Allegrucci; Yue-Zhong Wu; Alexandra Thurston; Chris N Denning; Helen Priddle; Christine L Mummery; Dorien Ward-van Oostwaard; Peter W Andrews; Miodrag Stojkovic; Nigel Smith; Tony Parkin; Mark Edmondson Jones; Graham Warren; Li Yu; Romulo Martin Brena; Christoph Plass; Lorraine E Young
Journal:  Hum Mol Genet       Date:  2007-04-04       Impact factor: 6.150

7.  Comparison of alignment software for genome-wide bisulphite sequence data.

Authors:  Aniruddha Chatterjee; Peter A Stockwell; Euan J Rodger; Ian M Morison
Journal:  Nucleic Acids Res       Date:  2012-02-16       Impact factor: 16.971

8.  Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.

Authors:  Aniruddha Chatterjee; Peter A Stockwell; Antonio Ahn; Euan J Rodger; Anna L Leichter; Michael R Eccles
Journal:  Oncotarget       Date:  2017-01-24

Review 9.  Gene-Specific Targeting of DNA Methylation in the Mammalian Genome.

Authors:  Arthur Urbano; Jim Smith; Robert J Weeks; Aniruddha Chatterjee
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

10.  Technical considerations for reduced representation bisulfite sequencing with multiplexed libraries.

Authors:  Aniruddha Chatterjee; Euan J Rodger; Peter A Stockwell; Robert J Weeks; Ian M Morison
Journal:  J Biomed Biotechnol       Date:  2012-10-10
View more
  4 in total

1.  Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.

Authors:  Flávia E Rius; Debora D Papaiz; Hatylas F Z Azevedo; Ana Luísa P Ayub; Diogo O Pessoa; Tiago F Oliveira; Ana Paula M Loureiro; Fernando Andrade; André Fujita; Eduardo M Reis; Christopher E Mason; Miriam G Jasiulionis
Journal:  Clin Epigenetics       Date:  2022-05-23       Impact factor: 7.259

Review 2.  Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.

Authors:  Jyoti Motwani; Michael R Eccles
Journal:  Genes (Basel)       Date:  2021-09-28       Impact factor: 4.096

3.  RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations.

Authors:  Olga Alexandra Sidorova; Shady Sayed; Maciej Paszkowski-Rogacz; Michael Seifert; Aylin Camgöz; Ingo Roeder; Martin Bornhäuser; Christian Thiede; Frank Buchholz
Journal:  Cells       Date:  2022-03-02       Impact factor: 6.600

4.  Magnetic Immunosensor Coupled to Enzymatic Signal for Determination of Genomic DNA Methylation.

Authors:  Yitao Liang; Bin Zhang; Zexin Xue; Xuesong Ye; Bo Liang
Journal:  Biosensors (Basel)       Date:  2022-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.